Stroke
Conditions
Interventions
Control group:Sertraline hydrochloride
Intervention group:Treatment with self-formulated traditional Chinese medicine combined with sertraline hydrochloride
Sponsors
The First Affiliated Hospital of Nanchang University
Eligibility
Sex/Gender
All
Age
19 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1) Meet the diagnostic criteria; 2) Over 18 years old; 3) Have a disease course lasting at least 2 weeks; 4) Have a mild to moderate degree of depression (8 = HAMD-24 score = 35); 5) Be willing to participate in the trial and sign the informed consent form.
Exclusion criteria
Exclusion criteria: Exclusion criteria: 1) Patients with severe cognitive dysfunction; 2) Patients with severe underlying diseases, such as liver and kidney dysfunction; 3) Patients with severe psychiatric symptoms such as mania. Criteria for withdrawal and dropout: 1) Patients who receive other related treatments without authorization during the treatment process; 2) Patients with poor compliance who fail to cooperate with the treatment as required; 3) Patients who experience allergic reactions or severe adverse reactions during the treatment observation period; 4) Patients who develop other serious diseases during the treatment process and cannot continue with the treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Therapeutic effect on neurological deficits; Evaluation of Traditional Chinese Medicine Syndrome Efficacy; Clinical efficacy of depression | — |
Secondary
| Measure | Time frame |
|---|---|
| Whether there are gastrointestinal reactions, insomnia, headaches and other discomfort symptoms; Record the occurrence of adverse drug reactions to evaluate their safety; | — |
Countries
China
Contacts
Public ContactLiqun Li
The First Affiliated Hospital of Nanchang University
Outcome results
None listed